Company News

Share this article:

Bristol-Myers Squibb will acquire Medarex, a biopharma focused on antibody-based therapeutics for the treatment life-threatening or debilitating diseases, for $2.4 billion. The deal includes full ownership of ipilimumab, a melanoma treatment in phase 3, which BMS called a potentially “important contributor to…future growth,” in a statement.

Digital detailer Physicians Interactive has acquired Skyscape, a mobile health information provider. Skyscape's user base exceeds one million medical practitioners, according to a release. Terms of the deal were not disclosed.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.